Cheree H. Johnson - 13 Jan 2023 Form 4 Insider Report for DENTSPLY SIRONA Inc. (XRAY)

Reporting relationship: SVP,Chief Legal Ofcr, GC &Sec
Issuer ticker: XRAY
Reported as of: 13 Jan 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 13 Jan 2023, 15:52:35 UTC
Prior SEC filing: 28 Nov 2022
Next SEC filing: 11 Jun 2024
Source filing: View source filing
Reporting owner signature: /s/ Dane Baumgardner, Attorney-In-Fact for Cheree H. Johnson

Key filing fact

Cheree H. Johnson filed Form 4 for DENTSPLY SIRONA Inc. (XRAY) on 13 Jan 2023.

Key facts

This page summarizes Cheree H. Johnson's Form 4 filing for DENTSPLY SIRONA Inc. (XRAY).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 13 Jan 2023, 15:52.

Change

Previous filing in this sequence was filed on 28 Nov 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

XRAY transaction

Common Stock

Award

Transaction value: $0
Shares: +291
Change %: +0.35%
Price: $0.000000
Shares after: 83,059
Date: 13 Jan 2023
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.

Footnote F2

Includes 184 shares acquired between June 1st - December 31, 2022 under the Dentsply Sirona Employee Stock Purchase Plan